Apixaban conferred lower bleeding risk during a 3-month period compared with rivaroxaban in patients with acute venous thromboembolism, researchers reported.Despite higher medication adherence to ...

The first clinical trial to compare two commonly used drugs head-to-head for venous thrombosis treatment has found a clear ...

Significantly lower risk for clinically relevant bleeding seen with apixaban than rivaroxaban during three-month trial period.

Uncontrolled bleeding represents one of the most alarming medical situations people encounter. While minor cuts and scrapes typically stop bleeding within minutes, persistent bleeding despite proper ...

A groundbreaking study with results published in European Heart Journal has unveiled critical insights into the risks associated with combining non-steroidal anti-inflammatory drugs (NSAIDs) with ...

We need our blood to walk a very fine line between flowing freely and clotting, and treatments for blood clots in the body naturally come with a risk of excessive bleeding from an injury. But now, ...

People with atrial fibrillation (Afib) who took low doses of blood-thinning drugs known as direct oral anticoagulants (DOACs) experienced more bleeding during the first three months of treatment.

Most people lose around 2–3 tablespoons of blood during their period. People with heavy periods may lose twice as much. Fatigue or weakness may be signs that a person is losing too much blood. This ...